GSTA inhibitors are a class of chemical compounds that specifically target and inhibit the activity of glutathione S-transferase alpha (GSTA), an enzyme belonging to the GST superfamily. GSTs are enzymes that play a significant role in cellular detoxification by catalyzing the conjugation of the antioxidant glutathione to a variety of substrates, including endogenous compounds and xenobiotics. The alpha class of GSTs (GSTA) is one of the several isoforms, distinguished by its substrate specificity, structure, and functional properties. Inhibitors of GSTA work by interfering with the enzyme's active site or by inducing conformational changes that reduce its catalytic efficiency. Such inhibitors often feature structural elements that mimic the enzyme's natural substrates or exploit specific binding interactions within the GSTA active site, leading to competitive, non-competitive, or allosteric inhibition. They may vary significantly in terms of their chemical scaffolds, ranging from small organic molecules to more complex derivatives.
The design and development of GSTA inhibitors require a detailed understanding of the enzyme's structure and the interactions it mediates. The active site of GSTA has a distinct architecture that can accommodate various chemical structures, allowing for specificity in inhibitor binding. The diversity of these inhibitors also extends to their physicochemical properties, with variations in solubility, stability, and reactivity. Some inhibitors are known to possess electrophilic groups capable of covalently modifying the enzyme, whereas others may be reversible binders that interact through non-covalent forces like hydrogen bonding, van der Waals interactions, or hydrophobic effects. Additionally, GSTA inhibitors are often analyzed for their selectivity towards GSTA isoforms to minimize off-target effects on other GST classes. Due to their ability to alter glutathione conjugation pathways, these inhibitors are powerful tools for studying cellular detoxification processes and the role of GSTAs in the metabolism of different endogenous and exogenous compounds.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ethacrynic acid | 58-54-8 | sc-257424 sc-257424A | 1 g 5 g | $49.00 $229.00 | 5 | |
Ethacrynic acid may conjugate to GSTA's active-site cysteine, potentially leading to irreversible inhibition and a subsequent decrease in the enzyme's cellular levels due to reduced protein stability and enhanced degradation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin could suppress GSTA expression by hindering the binding of transcription factors necessary for the initiation of GSTA gene transcription, thus silencing its promoter activity. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $94.00 $173.00 $255.00 $423.00 | 26 | |
Capsaicin may attenuate GSTA expression by disrupting the assembly of transcriptional machinery at the GSTA gene promoter, leading to a decrease in mRNA synthesis. | ||||||
Cadmium chloride, anhydrous | 10108-64-2 | sc-252533 sc-252533A sc-252533B | 10 g 50 g 500 g | $55.00 $179.00 $345.00 | 1 | |
Cadmium chloride exposure might lead to a reduction in GSTA expression by triggering miRNA-mediated silencing mechanisms that target the mRNA transcripts of the GSTA gene for degradation. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $87.00 $224.00 | ||
Arsenic trioxide could cause histone modifications around the GSTA gene locus, resulting in chromatin condensation and decreased access for transcription enzymes, thereby downregulating gene expression. | ||||||
Benzene | 71-43-2 | sc-239290 | 1 L | $77.00 | ||
Benzene might lead to the hypermethylation of CpG islands within the GSTA gene promoter, thus silencing its expression by hindering the binding of transcriptional activators. | ||||||
Diallyl sulfide | 592-88-1 | sc-204718 sc-204718A | 25 g 100 g | $41.00 $104.00 | 3 | |
Diallyl sulfide could inhibit GSTA expression by depleting available glutathione pools, leading to altered cellular redox status and a compensatory reduction in GSTA synthesis. | ||||||
Chlorpyrifos | 2921-88-2 | sc-217887 | 250 mg | $92.00 | ||
Chlorpyrifos may cause the attenuation of GSTA expression by triggering the release of cellular stress response elements that bind to and inhibit the GSTA gene promoter. | ||||||
Butylated hydroxyanisole | 25013-16-5 | sc-252527 sc-252527A | 5 g 100 g | $29.00 $96.00 | 1 | |
Butylated hydroxyanisole may lead to a decrease in GSTA expression by altering the redox-sensitive transcriptional control mechanisms that dictate the expression levels of this detoxification enzyme. | ||||||
Bis(2-ethylhexyl) phthalate | 117-81-7 | sc-254975 | 1 g | $56.00 | 2 | |
Bis(2-ethylhexyl) phthalate could reduce GSTA expression by interfering with peroxisome proliferator-activated receptor pathways that are crucial for the transcriptional initiation of GSTA gene expression. | ||||||